Pharmaceutical company Abbvie had its shares drop about 3% last week after California’s insurance commissioner Dave Jones sued the company, alleging Abbvie has been providing kickbacks in the form of nursing support and insurance assistance to prompt doctors to write prescriptions for its arthritis drug Humira.
Featured News
US Drops Antitrust Case Against German Fragrance Maker Symrise
Feb 9, 2026 by
CPI
Autodesk Sues Google Over Use of ‘Flow’ Trademark in AI Software Dispute
Feb 9, 2026 by
CPI
Indiana Reaches $6.25 Million Settlement in EpiPen Price-Fixing Case
Feb 9, 2026 by
CPI
Takeda Signs Up to $1.7B Deal to Use Iambic’s AI Technology for Drug Discovery
Feb 9, 2026 by
CPI
New York Becomes Sixth State to Propose Moratorium on Data Center Construction
Feb 9, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Hub-&-Spoke Conspiracies
Jan 26, 2026 by
CPI
A Data Analytics Company as the Hub in a Hub-and-Spoke Cartel
Jan 26, 2026 by
Joseph Harrington
Hub and Spoke Cartels
Jan 26, 2026 by
Patrick Van Cayseele
Hub-and-Spoke Collusion or Vertical Exclusion? Identifying the Rim in Hub-and-Spoke Conspiracies
Jan 26, 2026 by
Rosa Abrantes-Metz, Pedro Gonzaga, Laura Ildefonso & Albert Metz
The Algorithmic Middleman in a Hub-and-Spoke Conspiracy: Divergent Court Decisions and the Expanding Patchwork of State and Local Regulations
Jan 26, 2026 by
Bradley C. Weber